| Structure | Chemical Name | CAS | MF |
|
(S)-tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate
|
169448-17-3
|
C11H22N2O3
|
|
(R)-1-N-Boc-2-(hydroxymethyl)piperazine
|
169448-87-7
|
C10H20N2O3
|
|
(S)-1-[(4-Methoxyphenyl)methyl]pyrrolidin-3-amine dihydrochloride
|
169452-07-7
|
C12H19ClN2O
|
|
1-(4-FLUORO-BENZYL)-PYRROLIDIN-3-YLAMINE DIHYDROCHLORIDE
|
169452-08-8
|
C11H17Cl2FN2
|
|
(S)-1-(4-Methylbenzyl)pyrrolidin-3-aminedihydrochloride
|
169452-09-9
|
C12H19ClN2
|
|
1-(4-CHLORO-BENZYL)-PYRROLIDIN-3-YLAMINE DIHYDROCHLORIDE
|
169452-11-3
|
C11H16Cl2N2
|
|
(S)-1-(3-Methylbenzyl)pyrrolidin-3-aminedihydrochloride
|
169452-13-5
|
C12H19ClN2
|
|
(S)-1-(2-Methylbenzyl)pyrrolidin-3-aminedihydrochloride
|
169452-14-6
|
C12H20Cl2N2
|
|
1-(3-METHOXY-BENZYL)-PYRROLIDIN-3-YLAMINE DIHYDROCHLORIDE
|
169452-16-8
|
C12H20Cl2N2O
|
|
(S)-1-(2-Methoxybenzyl)pyrrolidin-3-amine dihydrochloride
|
169452-17-9
|
C12H19ClN2O
|
|
1-(3-FLUORO-BENZYL)-PYRROLIDIN-3-YLAMINE DIHYDROCHLORIDE
|
169452-20-4
|
C11H17Cl2FN2
|
|
(S)-1-(2-Fluorobenzyl)pyrrolidin-3-aminedihydrochloride
|
169452-21-5
|
C11H16ClFN2
|
|
1-FURAN-2-YLMETHYL-PYRROLIDIN-3-YLAMINE DIHYDROCHLORIDE
|
169452-23-7
|
C9H15ClN2O
|
|
(S)-1-(Pyridin-4-ylmethyl)pyrrolidin-3-amine trihydrochloride
|
169452-30-6
|
C10H18Cl3N3
|
|
1-PYRIDIN-3-YLMETHYL-PYRROLIDIN-3-YLAMINE TRIHYDROCHLORIDE
|
169452-31-7
|
C10H18Cl3N3
|
|
(S)-1-(pyridin-2-ylmethyl)pyrrolidin-3-amine trihydrochloride
|
169452-32-8
|
C10H16ClN3
|
|
Benzeneacetic acid, alpha-[[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]amino]-, methyl ester, [S-(R*,S*)]- (9CI)
|
169452-97-5
|
C18H28N2O3
|
|
L-Phenylalanine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169452-98-6
|
C19H30N2O3
|
|
L-Phenylalanine, N-[2-[(1,1-dimethylethyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-, methyl ester, (S)- (9CI)
|
169452-99-7
|
C23H30N2O3
|
|
Glycine, N-[N-[2-methoxy-2-oxo-1-(phenylmethyl)ethyl]-L-phenylalanyl]-, methyl ester, (S)- (9CI)
|
169453-00-3
|
C22H26N2O5
|
|
Glycine, N-[N-[2-methoxy-2-oxo-1-(phenylmethyl)ethyl]-D-phenylalanyl]-, methyl ester, (S)- (9CI)
|
169453-01-4
|
C22H26N2O5
|
|
L-Valine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169453-02-5
|
C15H30N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylpropyl]-L-valyl]-, methyl ester, (S)- (9CI)
|
169453-03-6
|
C14H26N2O5
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylpropyl]-L-valyl]-, ethyl ester, (S)- (9CI)
|
169453-04-7
|
C15H28N2O5
|
|
L-Methionine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169453-05-8
|
C15H30N2O3S
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-3-(methylthio)propyl]-L-valyl]-, ethyl ester, (S)- (9CI)
|
169453-06-9
|
C15H28N2O5S
|
|
L-Leucine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169453-07-0
|
C16H32N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-3-methylbutyl]-L-valyl]-, ethyl ester, (S)- (9CI)
|
169453-08-1
|
C16H30N2O5
|
|
L-Isoleucine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169453-09-2
|
C16H32N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylbutyl]-L-valyl]-, ethyl ester, [S-(R*,R*)]- (9CI)
|
169453-10-5
|
C16H30N2O5
|
|
L-Histidine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (S)- (9CI)
|
169453-11-6
|
C16H28N4O3
|
|
L-Aspartic acid, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, 4-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl] 1-methyl ester, [S-(R*,R*)]- (9CI)
|
169453-14-9
|
C23H43N3O6
|
|
Benzeneacetic acid, alpha-[[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]amino]-, methyl ester, [R-(R*,R*)]- (9CI)
|
169453-29-6
|
C18H28N2O3
|
|
L-Phenylalanine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169453-30-9
|
C19H30N2O3
|
|
L-Phenylalanine, N-[2-[(1,1-dimethylethyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-, methyl ester, (R)- (9CI)
|
169453-31-0
|
C23H30N2O3
|
|
L-Valine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169453-32-1
|
C15H30N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylpropyl]-D-valyl]-, methyl ester, (S)- (9CI)
|
169453-33-2
|
C14H26N2O5
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylpropyl]-D-valyl]-, ethyl ester, (S)- (9CI)
|
169453-34-3
|
C15H28N2O5
|
|
L-Methionine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169453-35-4
|
C15H30N2O3S
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-3-(methylthio)propyl]-D-valyl]-, ethyl ester, (S)- (9CI)
|
169453-36-5
|
C15H28N2O5S
|
|
L-Leucine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169453-37-6
|
C16H32N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-3-methylbutyl]-D-valyl]-, ethyl ester, (S)- (9CI)
|
169453-38-7
|
C16H30N2O5
|
|
L-Histidine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169453-39-8
|
C16H28N4O3
|
|
2-([1-(3-[[3-(DIMETHYL(3-[4-[(3-METHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)METHYLENE]-1(4H)-PYRIDINYL]PROPYL)AMMONIO)PROPYL](DIMETHYL)AMMONIO]PROPYL)-4(1H)-PYRIDINYLIDENE]METHYL)-3-METHYL-1,3-BENZOTHIAZOL-3-IUM TETRAIODIDE
|
169454-13-1
|
C41H54IN6S2+3
|
|
2-((E)-3-[1-(3-[[3-(DIMETHYL(3-[4-[(E)-3-(3-METHYL-1,3-BENZOTHIAZOL-3-IUM-2-YL)-2-PROPENYLIDENE]-1(4H)-PYRIDINYL]PROPYL)AMMONIO)PROPYL](DIMETHYL)AMMONIO]PROPYL)-4(1H)-PYRIDINYLIDENE]-1-PROPENYL)-3-METHYL-1,3-BENZOTHIAZOL-3-IUM TETRAIODIDE
|
169454-17-5
|
C45H58I4N6S2
|
|
N-BOC-4-(2-BROMO-ETHYL)-PIPERIDINE
|
169457-73-2
|
C12H22BrNO2
|
|
ETHYL 4-PIPERIDINEACETATE HCL
|
169458-04-2
|
C9H18ClNO2
|
|
(R)-1,3-dibenzylpiperazine
|
169458-69-9
|
C18H22N2
|
|
(S)-N4-BENZYL-2-(3-INDOLYLMETHYL)PIPERAZINE
|
169458-70-2
|
C20H23N3
|
|
5-CYANO-1H-INDOLE-2-CARBOXYLIC ACID
|
169463-44-9
|
C10H6N2O2
|
|
5-Cyano-3-methyl-1H-indole-2-carboxylic acid
|
169463-46-1
|
C11H8N2O2
|
|
1-ACETYL-4-(2-THIENYL)-1H-PYRROLE-3-CARBOXYLIC ACID ETHYL ESTER
|
169467-62-3
|
C13H13NO3S
|
|
1H-Pyrrole, 1,3-diacetyl-4-methyl- (9CI)
|
169467-63-4
|
C9H11NO2
|
|
4-CHLORO-2,3-DIFLUORONITROBENZENE
|
169468-80-8
|
C6H2ClF2NO2
|
|
5-Chloro-1,2-difluoro-3-nitrobenzene
|
169468-81-9
|
C6H2ClF2NO2
|
|
2-Chloro-3,4-difluoronitrobenzene
|
169468-83-1
|
C6H2ClF2NO2
|
|
4(3H)-Quinazolinone, 2-(((4-((2-chlorophenyl)methylene)-5-oxo-2-thioxo -1-imidazolidinyl)imino)methyl)-3-phenyl-
|
169471-14-1
|
C25H16ClN5O2S
|
|
4(3H)-Quinazolinone, 2-(((4-((2-methoxyphenyl)methylene)-5-oxo-2-thiox o-1-imidazolidinyl)imino)methyl)-3-phenyl-
|
169471-15-2
|
C26H19N5O3S
|
|
4(3H)-Quinazolinone, 2-(((4-((4-methoxyphenyl)methylene)-5-oxo-2-thiox o-1-imidazolidinyl)imino)methyl)-3-phenyl-
|
169471-16-3
|
C26H19N5O3S
|
|
1,3-BispalMitoyl-2-chloropropanediol
|
169471-41-4
|
C35H67ClO4
|
|
PERFLUORO-2-TRIFLUOROMETHYL-4-OXANONANE
|
169477-62-7
|
C9F20O
|
|
2-Propynoic acid, 3-(1-cyclopenten-1-yl)-, methyl ester (9CI)
|
169478-78-8
|
C9H10O2
|
|
BIS(S,S-(2-DIISOPROPYLAMINOETHYL)METHYLPHOSPHONODITHIOLATE
|
169493-13-4
|
C17H39N2OPS2
|
|
ethyl2-aMino-5-chloronicotinate
|
169495-51-6
|
C8H9ClN2O2
|
|
2-Azetidinone, 4-ethynyl-1-(hydroxymethyl)-, (S)- (9CI)
|
169498-58-2
|
C6H7NO2
|
|
Ethanone, 1-(4,5,6,7-tetrahydro-1H-indol-3-yl)- (9CI)
|
169501-32-0
|
C10H13NO
|
|
4,4'-METHYLENEBIS(2,6-DIISOPROPYL-N,N-DIMETHYLANILINE)
|
169501-63-7
|
C29H46N2
|
|
3,4-dihydro-1-[(4-methoxyphenyl)methyl]-1H-1,4-Benzodiazepine-2,5-dione
|
169504-53-4
|
C17H16N2O3
|
|
(N-[2-(2-CYCLOPROPYLMETHOXYPHENOXY)ETHYL]-5-CHLORO-ALPHA,ALPHA-DIMETHYL-1H-INDOLE-3-ETHANAMINE) HYDROCHLORIDE
|
169505-93-5
|
C24H30Cl2N2O2
|
|
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate
|
169506-15-4
|
C11H16O5S
|
|
2,4,5-TRIFLUORO-3-ETHOXY BENZOIC ACID
|
169507-61-3
|
C9H7F3O3
|
|
2-(5-Oxazolyl)benzoic Acid
|
169508-94-5
|
C10H7NO3
|
|
Pyrazolo[3,4-d]-1,2,3-triazol-6(1H)-one, 4,5-dihydro-4,5-dimethyl- (9CI)
|
169511-84-6
|
C5H7N5O
|
|
Pyrrolo[2,3-d]-1,2,3-triazole, 1,4-dihydro-4-methyl- (9CI)
|
169511-86-8
|
C5H6N4
|
|
1H-Thiazolo[4,5-d]-1,2,3-triazole, 5-methyl- (9CI)
|
169511-88-0
|
C4H4N4S
|
|
4-Chloro-7-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-7H-pyrrolo[2.3-d]pyriMidine
|
169516-55-6
|
C25H19ClFN3O5
|
|
4-Chloro-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-7H-pyrrolo[2.3-d]pyriMidine
|
169516-60-3
|
C11H11ClFN3O3
|
|
4-AMino-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-7H-pyrrolo[2.3-d]pyriMidine
|
169516-61-4
|
C11H13FN4O3
|
|
2-(2-METHYL-2-PROPENOYLOXY)ETHYL 3-HYDROXYBUTANOATE
|
169518-50-7
|
C10H16O5
|
|
Ethenone, (2-ethynyl-1-cyclopenten-1-yl)- (9CI)
|
169522-24-1
|
C9H8O
|
|
L-Lysine-2-13C hydrochloride
|
169524-86-1
|
H2N(CH2)413CH(NH2)CO2H⋅HCl
|
|
Pentalene, octahydro-2,5-dinitro-, (2-alpha-,3a-ba-,5-alpha-,6a-ba-)- (9CI)
|
169525-05-7
|
C8H12N2O4
|
|
Pentalene, octahydro-2,5-dinitro-, (2-alpha-,3a-alpha-,5-ba-,6a-alpha-)- (9CI)
|
169525-06-8
|
C8H12N2O4
|
|
Pentalene, octahydro-2,5-dinitro-, (2-alpha-,3a-alpha-,5-alpha-,6a-alpha-)- (9CI)
|
169525-07-9
|
C8H12N2O4
|
|
3,6-Diazabicyclo[3.1.0]hexane,6-(1,1-dimethylethyl)-2-methyl-,[1S-(1-alpha-,2-bta-,5-alpha-)]-(9CI)
|
169525-62-6
|
C9H18N2
|
|
Benzoic acid, 2-[(2-methylpropyl)amino]- (9CI)
|
169527-46-2
|
C11H15NO2
|
|
(1S-TRANS)-2-(4-TERT-BUTYLPHENOXY)CYCLOHEXANOL
|
169527-71-3
|
C16H24O2
|
|
PD-149163
|
169528-11-4
|
C42H71N9O6
|
|
[R-(R*,S*)]-9-Cyano-6-(2-cyanoethoxy)-3-(1-hydroxyhexadecyl)-5,7-dioxa-2-aza-6-phosphanonanoic Acid 6-Oxide 1,1-DiMethylethyl Ester
|
169528-22-7
|
C29H54N3O7P
|
|
D-3-NITROPHENYLALANINE
|
169530-97-6
|
C9H10N2O4
|
|
Ethyl 2,3,4-Tri-O-benzyl-1-thio-α,-L-fucopyranoside
|
169532-17-6
|
C29H34O4S
|
|
(S)-1-Cyclohexylpyrrolidin-3-amine dihydrochloride
|
169532-93-8
|
C10H22Cl2N2
|
|
(R)-1-Cyclohexylpyrrolidin-3-amine dihydrochloride
|
169532-94-9
|
C10H22Cl2N2
|
|
L-Isoleucine, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, methyl ester, (R)- (9CI)
|
169533-20-4
|
C16H32N2O3
|
|
Glycine, N-[N-[1-(methoxycarbonyl)-2-methylbutyl]-D-valyl]-, ethyl ester, [S-(R*,R*)]- (9CI)
|
169533-21-5
|
C16H30N2O5
|
|
L-Aspartic acid, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, 4-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl] 1-methyl ester, [R-(R*,R*)]- (9CI)
|
169533-22-6
|
C23H43N3O6
|
|
L-Aspartic acid, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, 4-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl] 1-methyl ester, [S-(R*,S*)]- (9CI)
|
169533-23-7
|
C23H43N3O6
|
|
L-Aspartic acid, N-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl]-, 4-[1-[[(1,1-dimethylethyl)amino]carbonyl]-2-methylpropyl] 1-methyl ester, [R-(R*,S*)]- (9CI)
|
169533-24-8
|
C23H43N3O6
|
|
Moxifloxacin Related Impurity 2
|
169533-56-6
|
C7H14N2
|
|
ProtosteMotinine
|
169534-85-4
|
C23H29NO6
|